collection
Collections Most Read Papers - Surgery - V...

Most Read Papers - Surgery - Vascular

Most Read Papers - Surgery - Vascular

https://read.qxmd.com/read/38617100/non-obese-lipedema-patients-show-a-distinctly-altered-quantitative-sensory-testing-profile-with-high-diagnostic-potential
#1
JOURNAL ARTICLE
Rebecca Dinnendahl, Dominik Tschimmel, Vanessa Löw, Manuel Cornely, Tim Hucho
INTRODUCTION AND OBJECTIVES: Lipedema is a widespread severe chronic disease affecting mostly women. Characterized by painful bilateral fat accumulation in extremities sparing hands and feet, objective measurement-based diagnosis is currently missing. We tested for characteristic psychometric and/or sensory alterations including pain and for their potential for medical routine diagnosis. METHODS: Pain psychometry was assessed using the German Pain Questionnaire...
June 2024: Pain Reports
https://read.qxmd.com/read/38492760/vascular-access-device-type-for-systemic-anti-cancer-therapies-in-cancer-patients-a-scoping-review
#2
REVIEW
C Duggan, O Hernon, R Dunne, V McInerney, S R Walsh, A Lowery, M McCarthy, P J Carr
BACKGROUND: Patients with cancer can expect to receive numerous invasive vascular access procedures for intravenous therapy and clinical diagnostics. Due to the increased incidence and prevalence of cancer globally there will be significantly more people who require first-line intravenous chemotherapy over the next ten years. METHODS: Our objective was to determine the types of evidence that exist for the vascular access device (VAD) type for the delivery of systemic anti-cancer therapy (SACT) in cancer patients...
April 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38614140/assessment-of-fitness-for-open-repair-in-patients-with-infrarenal-abdominal-aortic-aneurysms
#3
JOURNAL ARTICLE
Mitri K Khoury, Micah A Thornton, Matthew J Eagleton, Sunita D Srivastava, Nikolaos Zacharias, Anahita Dua, Abhisekh Mohapatra
INTRODUCTION: Endovascular aortic repair (EVAR) was originally designed as a treatment modality for patients with abdominal aortic aneurysms (AAAs) deemed unfit for open repair. However, the definition of "unfit for open repair" is largely subjective and heterogenous. The purpose of this study was to compare patients deemed unfit for open repair who underwent EVAR to a matched cohort who underwent open repair for infrarenal AAAs. METHODS: The Vascular Quality Initiative (VQI) of the Society for Vascular Surgery (SVS) was queried for patients who underwent EVAR and open infrarenal AAA repair from 2003-2022...
April 11, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38350768/covid-19-vaccines-and-adverse-events-of-special-interest-a-multinational-global-vaccine-data-network-gvdn-cohort-study-of-99-million-vaccinated-individuals
#4
JOURNAL ARTICLE
K Faksova, D Walsh, Y Jiang, J Griffin, A Phillips, A Gentile, J C Kwong, K Macartney, M Naus, Z Grange, S Escolano, G Sepulveda, A Shetty, A Pillsbury, C Sullivan, Z Naveed, N Z Janjua, N Giglio, J Perälä, S Nasreen, H Gidding, P Hovi, T Vo, F Cui, L Deng, L Cullen, M Artama, E Weintraub, H Lu, H J Clothier, K Batty, J Paynter, H Petousis-Harris, J Buttery, S Black, A Hviid
BACKGROUND: The Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries. METHODS: Using a common protocol, this observational cohort study compared observed with expected rates of 13 selected AESI across neurological, haematological, and cardiac outcomes...
February 12, 2024: Vaccine
https://read.qxmd.com/read/38613686/the-boon-and-bane-of-nitrous-oxide
#5
REVIEW
Golo Kronenberg, Georgios Schoretsanitis, Erich Seifritz, Sebastian Olbrich
Nitrous oxide (N2O) has been known since the end of the eighteenth century. Today, N2O plays a huge role as a greenhouse gas and an ozone-depleting stratospheric molecule. The main sources of anthropogenic N2O emissions are agriculture, fuel combustion, wastewater treatment, and various industrial processes. By contrast, the contribution of medical N2O to the greenhouse effect appears to be small. The recreational and medical uses of N2O gradually diverged over time. N2O has analgesic and anesthetic effects, making it widely used in modern dentistry and surgery...
April 13, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38561205/management-of-lower-extremity-venous-thromboembolism-an-updated-review
#6
REVIEW
Farah Ziyadeh, Yael Mauer
According to the 2021 updated guidelines of the American College of Chest Physicians, the location of venous thromboembolism, the severity of symptoms, the risk of thrombus extension vs that of bleeding, and comorbidities all affect the decision to treat, the choice of anti-thrombotic agent, and the duration of therapy. In patients with isolated distal deep vein thrombosis without high-risk features, monitoring progression is recommended over initiating anticoagulation. However, treatment of proximal deep vein thrombosis with anticoagulation is strongly recommended by the guidelines...
April 1, 2024: Cleveland Clinic Journal of Medicine
https://read.qxmd.com/read/38562065/antithrombotic-therapy-for-stable-coronary-artery-disease-and-atrial-fibrillation-in-patients-with-and-without-revascularisation-the-afire-trial
#7
JOURNAL ARTICLE
Takashi Noda, Kotaro Nochioka, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa, Satoshi Yasuda, On Behalf Of The Afire Investigators
BACKGROUND: The Atrial Fibrillation and Ischemic Events with Rivaroxaban in Patients with Stable Coronary Artery Disease (AFIRE) trial demonstrated non-inferior efficacy endpoints for rivaroxaban monotherapy versus combination therapy (rivaroxaban plus a single antiplatelet) and superior safety endpoints in patients with atrial fibrillation and stable coronary artery disease. AIMS: This post hoc analysis investigated whether the AFIRE trial results reflected the presence or absence of prior revascularisation...
April 1, 2024: EuroIntervention
https://read.qxmd.com/read/38580160/branched-and-fenestrated-endovascular-aortic-arch-repair-in-patients-with-native-proximal-aortic-landing-zone
#8
JOURNAL ARTICLE
Petroula Nana, Konstantinos Spanos, Giuseppe Panuccio, Fiona Rohlffs, Christian Detter, Yskert von Kodolitsch, José I Torrealba, Tilo Kölbel
INTRODUCTION: Fenestrated and branched thoracic endovascular repair (f/bTEVAR) have been successfully applied in patients with diverse aortic arch pathologies. The aim of this study is to present the early and mid-term outcomes of patients with native proximal aortic landing (NPAL) managed with f/bTEVAR. METHODS: A single-center retrospective analysis of patients with NPAL, managed with f/bTEVAR, between September 1st , 2011, and June 30th , 2022, was conducted...
April 3, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38574572/polidocanol-foam-treatment-of-varicose-veins-quality-of-life-impact-compared-to-conventional-surgery
#9
JOURNAL ARTICLE
Lissa Severo Sakugawa, Felipe Soares Oliveira Portela, Andressa Cristina Sposato Louzada, Maria Fernanda Cassino Portugal, Marcelo Passos Teivelis, Cynthia de Almeida Mendes, Lucas Lembrança Pinheiro, Marcelo Fiorelli Alexandrino da Silva, Alexandre Fioranelli, Nelson Wolosker
BACKGROUND AND OBJECTIVE: Lower limb varicose veins are a prevalent disease associated with several available treatment options, including conventional surgery and polidocanol foam sclerotherapy. However, few studies have analyzed therapeutic modality outcomes based on Patient-Reported Outcome Measures (PROMs). This large sample-size study was designed to evaluate the outcomes of polidocanol foam sclerotherapy compared to conventional surgery based on an analysis of PROMs. METHODS: This was a prospective, observational, and qualitative study of 205 patients who underwent varicose vein treatment with either polidocanol foam sclerotherapy (57 patients, 90 legs) or conventional surgery (148 patients, 236 legs)...
2024: Clinics
https://read.qxmd.com/read/38580159/prevalence-characteristics-evaluation-and-management-of-carotid-body-tumors-systematic-analysis-based-on-available-evidence
#10
REVIEW
Yong-Hong Wang, Jia Yang, Hao Zhong, Jun-Jie Wu, Kai Wu, Anguo Hu, Jian-Ying Wu, Ji-Hai Zhu
BACKGROUND: Although carotid body tumors (CBTs) are rare, they attract particular attention because of their propensity for malignant transformation and the high surgical risk. Because data are scarce and as it is difficult to achieve a large sample size, no study has yet comprehensively analyzed the characteristics, management, or operative complications of CBTs. Therefore, we collected and analyzed all currently available information on CBTs and used the pooled data to derive quantitative information on disease characteristics and management...
April 3, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38551527/the-anterior-saphenous-vein-part-2-anatomic-considerations-in-normal-and-refluxing-patients-endorsed-by-the-american-vein-and-lymphatic-society-the-american-venous-forum-and-the-international-union-of-phlebology
#11
JOURNAL ARTICLE
Alberto Caggiati, Nicos Labropoulos, Edward M Boyle, Rachel Drgastin, Antonios Gasparis, Suat Doganci, Mark Meissner
BACKGROUND: The term Anterior Accessory of the Great Saphenous Vein suggests this is a branch tributary vein despite this vessel's anatomic features of a truncal vein. A multisocietal group suggested to designate this the anterior saphenous vein (ASV). This study was aimed to evaluate its ultrasound anatomy in normal and varicose limbs. METHODS: The clinical anatomy of the ASV was evaluated by narrative review of the literature. Additionally, the course of the ASV was evaluated in 62 limbs with no evidence of venous disease and 62 limbs with varicosities...
March 22, 2024: Journal of Vascular Surgery. Venous and Lymphatic Disorders
https://read.qxmd.com/read/38526841/emergency-department-resuscitative-endovascular-balloon-occlusion-of-the-aorta-in-trauma-patients-with-exsanguinating-hemorrhage-the-uk-reboa-randomized-clinical-trial
#12
EDITORIAL
Thariq Badiudeen, Venkatesh Thiruganasambandamoorthy, Hans Rosenberg
No abstract text is available yet for this article.
March 25, 2024: CJEM
https://read.qxmd.com/read/38543075/dyslipidemia-a-narrative-review-on-pharmacotherapy
#13
REVIEW
Lucas Lentini Herling de Oliveira, Arthur Cicupira Rodrigues de Assis, Viviane Zorzanelli Rocha Giraldez, Thiago Luis Scudeler, Paulo Rogério Soares
Dyslipidemia plays a fundamental role in the development and progression of atherosclerosis. Current guidelines for treating dyslipidemia focus on low-density lipoprotein-cholesterol (LDL-C). Despite advances in the pharmacotherapy of atherosclerosis, the most successful agents used to treat this disease-statins-remain insufficient in the primary or secondary prevention of acute myocardial infarction. Advancing therapy for hypercholesterolemia with emerging new drugs, either as monotherapy or in combination, is expected to improve cardiovascular outcomes...
February 23, 2024: Pharmaceuticals
https://read.qxmd.com/read/38565344/aorto-bifemoral-bypass-versus-covered-endovascular-reconstruction-of-aortic-bifurcation
#14
JOURNAL ARTICLE
Dana B Semaan, Salim G Habib, Othman M Abdul-Malak, Jeffrey J Siracuse, Michael C Madigan, Karim M Salem, Rabih A Chaer, Mohammad H Eslami
BACKGROUND: Covered endovascular reconstruction of aortic bifurcation (CERAB) is increasingly utilized as a first line treatment in patients with aorto-iliac occlusive disease (AIOD). We sought to compare the outcomes of patients undergoing CERAB compared to the gold standard of aorto-bifemoral bypass (ABF). METHODS: The Vascular Quality Initiative was queried for patients undergoing ABF or CERAB from 2009-2021. Propensity scores were generated using demographics, comorbidities, Rutherford class, and urgency...
March 31, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38420547/covering-the-intercostal-artery-branching-of-the-adamkiewicz-artery-during-endovascular-aortic-repair-increases-the-risk-of-spinal-cord-ischemia
#15
JOURNAL ARTICLE
Yoshimasa Seike, Tatsuya Nishii, Kazufumi Yoshida, Koki Yokawa, Kenta Masada, Yosuke Inoue, Tetsuya Fukuda, Hitoshi Matsuda
OBJECTIVES: This study aimed to determine the relationship between covering the intercostal artery branching of the Adamkiewicz artery (ICA-AKA) and spinal cord ischemia (SCI) during thoracic endovascular aortic repair (TEVAR). METHODS: Patients who underwent TEVAR from 2008 to 2022 were enrolled. Stent grafts covered the ICA-AKA in 108 patients (covered AKA group) and stent grafts didn't cover the ICA-AKA in 114 patients (uncovered AKA group). The characteristics of 58 patients from each group were matched based on propensity scores...
February 2024: JTCVS open
https://read.qxmd.com/read/38522583/infra-inguinal-bypass-surgery-versus-endovascular-revascularization-for-chronic-limb-threatening-ischemia-in-average-and-high-risk-patients
#16
JOURNAL ARTICLE
Koichi Morisaki, Daisuke Matsuda, Atsushi Guntani, Go Kinoshita, Shinichiro Yoshino, Kentaro Inoue, Kenichi Honma, Terutoshi Yamaoka, Shinsuke Mii, Tomoharu Yoshizumi
OBJECTIVE: This study aimed to evaluate treatment outcomes after bypass surgery or endovascular therapy (EVT) in average- and high-risk patients with chronic limb-threatening ischemia (CLTI). METHODS: We retrospectively analyzed multicenter data of patients who underwent infra-inguinal revascularization for CLTI between 2015 and 2022. A high-risk patient was defined as one with estimated 30-day mortality rate ≥ 5% or 2-year survival rate ≤ 50%, as determined by the Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia (SPINACH) calculator...
March 22, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38521956/predictive-factors-of-thoracic-aortic-calcification-in-patients-candidate-for-cardiac-surgery
#17
JOURNAL ARTICLE
Amin Bagheri, Shapour Shirani, Arash Jalali, Shahrzad Salehbeigi, Jamshid Bagheri
BACKGROUND: The presence of the severe thoracic aortic calcification (TAC) in cardiac surgery patients is associated with adverse post-operative outcome. However, the relationship between cardiovascular risk factors and aortic plaque burden remains unknown. The objective of this study was to determine the predictive factors of TAC in patients candidate for cardiac surgery. METHODS: Patients who underwent thoracic CT scan prior to cardiac surgery between August 2020 to April 2021 were included...
March 23, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38537880/systematic-review-examining-the-association-of-angiotensin-converting-enzyme-inhibitor-and-angiotensin-receptor-blocker-prescription-with-abdominal-aortic-aneurysm-growth-and-events
#18
REVIEW
Kevin Tian, Shivshankar Thanigaimani, Kate Gibson, Jonathan Golledge
OBJECTIVE: Whether angiotensin II blockade is an effective medical treatment for abdominal aortic aneurysms (AAAs) has not been established. This systematic review and meta-analysis aimed to determine the association of angiotensin converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) prescription with AAA growth and events. DATA SOURCES: MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library databases were searched from their inception to 4 January 2024, with no language restrictions...
March 25, 2024: European Journal of Vascular and Endovascular Surgery
https://read.qxmd.com/read/38534886/drug-drug-interactions-of-fxi-inhibitors-clinical-relevance
#19
REVIEW
Nicola Ferri, Elisa Colombo, Alberto Corsini
Inhibitors of the factor FXI represent a new class of anticoagulant agents that are facing clinical approval for the treatment of acute coronary syndrome (ACS), venous thromboembolism (VTE), and stroke prevention of atrial fibrillation (AF). These new inhibitors include chemical small molecules (asundexian and milvexian), monoclonal antibodies (abelacimab, osocimab, and xisomab), and antisense oligonucleotides (IONIS-FXIRX and fesomersen), and thus, they have very peculiar and different pharmacokinetic and pharmacodynamic properties...
March 21, 2024: Hematology Reports
https://read.qxmd.com/read/34355758/how-to-live-to-100-before-developing-clinical-coronary-artery-disease-a-suggestion
#20
JOURNAL ARTICLE
Eugene Braunwald
No abstract text is available yet for this article.
January 31, 2022: European Heart Journal
label_collection
label_collection
1074
1
2
2024-04-02 00:25:19
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.